Abstract
Wingless-type MMTV integration site (Wnt) family molecules, a family of secreted glycoproteins have now gathered attention as a therapeutic target. Drug innovation targeting the canonical Wnt pathway is in the most interest since its molecular mechanism is well understood and clinical trials are in progress for osteoporosis. Recent findings have revealed the contribution of the non-canonical Wnt pathway in malignant tumors suggesting this pathway as a new treatment target, but it is relatively less understood. Recently, several reports have demonstrated the involvement of the non-canonical Wnt pathway in the bone metabolism. Therefore, we have compiled the current understanding of the non-canonical Wnt pathway in association with bone metabolism.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
